FRPT vs HIMS

For growth investors, Hims & Hers Health, Inc.

(HIMS) is the stronger pick with 59. 0% revenue growth year-over-year, versus 13. 0% for Freshpet, Inc. (FRPT). Freshpet, Inc. (FRPT) offers the better valuation at 20. 8x trailing P/E (40. 4x forward), making it the more compelling value choice. Analysts rate Freshpet, Inc. (FRPT) a "Buy" — based on 29 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Freshpet, Inc.

(FRPT) is the cheapest at 20. 8x versus Hims & Hers Health, Inc. at 52. 7x. On forward P/E, Freshpet, Inc. is actually cheaper at 40. 4x.

Over the past 5 years, Hims & Hers Health, Inc.

(HIMS) delivered a total return of +150. 5%, compared to -68. 1% for Freshpet, Inc. (FRPT). Over 10 years, the gap is even starker: FRPT returned +515. 1% versus HIMS's +174. 3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Freshpet, Inc.

(FRPT) is the lower-risk stock at 0. 91β versus Hims & Hers Health, Inc. 's 2. 40β — meaning HIMS is approximately 165% more volatile than FRPT relative to the S&P 500. On balance sheet safety, Freshpet, Inc. (FRPT) carries a lower debt/equity ratio of 46% versus 2% for Hims & Hers Health, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Hims & Hers Health, Inc.

(HIMS) is pulling ahead at 59. 0% versus 13. 0% for Freshpet, Inc. (FRPT). On earnings-per-share growth, the picture is similar: Freshpet, Inc. grew EPS 183. 9% year-over-year, compared to -3. 8% for Hims & Hers Health, Inc.. Over a 3-year CAGR, HIMS leads at 64. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Freshpet, Inc.

(FRPT) is the more profitable company, earning 12. 6% net margin versus 5. 5% for Hims & Hers Health, Inc. — meaning it keeps 12. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: FRPT leads at 8. 6% versus 5. 2% for HIMS. At the gross margin level — before operating expenses — HIMS leads at 59. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, Freshpet, Inc.

(FRPT) trades at 40. 4x forward P/E versus 53. 9x for Hims & Hers Health, Inc. — 13. 5x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for FRPT: 33. 7% to $73. 42.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, Freshpet, Inc.

(FRPT) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 91), +515. 1% 10Y return). Hims & Hers Health, Inc. (HIMS) carries a higher beta of 2. 40 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (FRPT: +515. 1%, HIMS: +174. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (FRPT (Consumer Defensive) and HIMS (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: FRPT is a small-cap quality compounder stock; HIMS is a small-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.